BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30553401)

  • 1. The omega-3 index in patients with heart failure: A prospective cohort study.
    Berliner D; Mattern S; Wellige M; Malsch C; Güder G; Brenner S; Morbach C; Deubner N; Breunig M; Kiefl R; Angermann CE; Ertl G; von Schacky C; Störk S
    Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():34-41. PubMed ID: 30553401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial.
    Lechner K; Scherr J; Lorenz E; Lechner B; Haller B; Krannich A; Halle M; Wachter R; Duvinage A; Edelmann F
    Clin Res Cardiol; 2022 Mar; 111(3):308-321. PubMed ID: 34453204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.
    Mozaffarian D; Lemaitre RN; King IB; Song X; Spiegelman D; Sacks FM; Rimm EB; Siscovick DS
    Ann Intern Med; 2011 Aug; 155(3):160-70. PubMed ID: 21810709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated versus single measurement of plasma omega-3 fatty acids and risk of heart failure.
    Djoussé L; Petrone AB; Weir NL; Hanson NQ; Glynn RJ; Tsai MY; Gaziano JM
    Eur J Nutr; 2014 Sep; 53(6):1403-8. PubMed ID: 24395612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Plasma Docosahexaenoic Acid Associated to Better Prognoses of Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction.
    Matsuo N; Miyoshi T; Takaishi A; Kishinoue T; Yasuhara K; Tanimoto M; Nakano Y; Onishi N; Ueeda M; Ito H
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33530352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.
    Watanabe S; Yoshihisa A; Kanno Y; Takiguchi M; Yokokawa T; Sato A; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Card Fail; 2016 Dec; 22(12):962-969. PubMed ID: 27138463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study.
    Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
    Atherosclerosis; 2016 Sep; 252():175-181. PubMed ID: 27397734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
    Nagai T; Honda Y; Sugano Y; Nishimura K; Nakai M; Honda S; Iwakami N; Okada A; Asaumi Y; Aiba T; Noguchi T; Kusano K; Ogawa H; Yasuda S; Anzai T;
    PLoS One; 2016; 11(11):e0165841. PubMed ID: 27824904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating plasma and whole blood fatty acid compositional data into the sum of eicosapentaenoic and docosahexaenoic acid in erythrocytes.
    Stark KD; Aristizabal Henao JJ; Metherel AH; Pilote L
    Prostaglandins Leukot Essent Fatty Acids; 2016 Jan; 104():1-10. PubMed ID: 26802936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids.
    Fernandes LP; Murai IH; Fernandes AL; Sales LP; Rogero MM; Gualano B; Barroso LP; Milne GL; Pereira RMR; Castro IA
    Sci Rep; 2024 May; 14(1):10238. PubMed ID: 38702342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies.
    Harris WS; Del Gobbo L; Tintle NL
    Atherosclerosis; 2017 Jul; 262():51-54. PubMed ID: 28511049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
    J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Docosahexaenoic Acid, Dihomo-Gamma-Linolenic Acid, and Arachidonic Acid Levels Associated with Long-Term Mortality in Patients with Acute Decompensated Heart Failure in Different Nutritional Statuses.
    Ouchi S; Miyazaki T; Shimada K; Sugita Y; Shimizu M; Murata A; Kato T; Aikawa T; Suda S; Shiozawa T; Hiki M; Takahashi S; Iwata H; Kasai T; Miyauchi K; Daida H
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study.
    Miura K; Hughes MCB; Ungerer JP; Green AC
    Nutr Res; 2016 Nov; 36(11):1202-1209. PubMed ID: 27865614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction--data from Infarction Prognosis Study (IPS) Registry.
    Lee SH; Shin MJ; Kim JS; Ko YG; Kang SM; Choi D; Jang Y; Chung N; Shim WH; Cho SY; Manabe I; Ha JW
    Circ J; 2009 Dec; 73(12):2250-7. PubMed ID: 19789416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.
    Sarter B; Kelsey KS; Schwartz TA; Harris WS
    Clin Nutr; 2015 Apr; 34(2):212-8. PubMed ID: 24679552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.
    Pottala JV; Garg S; Cohen BE; Whooley MA; Harris WS
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):406-12. PubMed ID: 20551373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
    Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
    Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.